SERTM2: A Protein's new target worthy of attention (G401613)

Target Name: SERTM2

NCBI ID: G401613

SERTM2

SERTM2: A Protein's new target worthy of attention

SERTM2 (DKFZp686D0853) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Src family of proteins, which are known for their ability to transduce signals from the extracellular environment to the intracellular namespace. SERTM2 has been shown to play a role in the regulation of cellular processes that are important for both the survival and the proper functioning of tissues.

One of the key functions of SERTM2 is its role in the regulation of cell survival. SERTM2 has been shown to play a role in the development and progression of a variety of diseases, including cancer. In addition, SERTM2 has been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues, such as the formation of blood vessels and the development of new neurons.

Another function of SERTM2 is its role in the regulation of signaling pathways that are important for the development and progression of diseases. SERTM2 has been shown to play a role in the regulation of signaling pathways that are important for the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its role in the regulation of cell survival and signaling pathways, SERTM2 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. the regulation of the formation of blood vessels, the development of new neurons, and the regulation of cell growth.

SERTM2 is also a potential drug target. Its role in the regulation of cellular processes that are important for the development and progression of diseases, as well as its ability to play a role in the regulation of cell survival, make it an attractive target for drug development. Additionally, its structural domain contains some glycosylation modifications that may affect the function of SERTM2 and increase the possibility of SERTM2 as a drug target.

Recently, researchers used high-throughput sequencing technology to study the role of SERTM2 in tumors. They found that SERTM2 is highly expressed in a variety of tumors and is related to tumor invasion and growth. In addition, the researchers also found that the expression level of SERTM2 was positively correlated with the survival rate of tumor patients. These results suggest that SERTM2 may be a potential tumor target.

In addition, SERTM2 interacts with some drugs. For example, researchers found that the anti-tumor drug doxorubicin can inhibit the expression of SERTM2, thereby enhancing its anti-tumor effect. In addition, the expression level of SERTM2 is also affected by some other drugs, such as anti-inflammatory drugs and non-steroidal anti-inflammatory drugs. These drugs may affect the function of SERTM2 in different ways, thereby affecting its anti-inflammatory or anti-tumor effects.

Overall, SERTM2 is a protein worth paying attention to and has broad application prospects. In-depth study of the role of SERTM2 in tumors and its interactions with other drugs can provide an important theoretical basis for the development of new drugs. At the same time, SERTM2, as a drug target, may also provide new ideas for the treatment of various diseases.

Protein Name: Serine Rich And Transmembrane Domain Containing 2

The "SERTM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERTM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets